Cargando…
Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program
AIM: Anticoagulants (AC) and anti-platelet (AP) agents are widely administered to patients with hematological malignancies (HM). However, HM patients may be at high risk of bleeding and hemorrhagic complications, because of different form of coagulopathies and several degrees of thrombocytopenia. MA...
Autores principales: | Tendas, Andrea, Cupelli, Luca, Scaramucci, Laura, Palombi, Massimiliano, Trawinska, Malgorzata Monika, Giovannini, Marco, Brunetti, Gregorio Antonio, Cartoni, Claudio, Bondanini, Francesco, de Fabritiis, Paolo, Niscola, Pasquale |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098544/ https://www.ncbi.nlm.nih.gov/pubmed/21633622 http://dx.doi.org/10.4103/0973-1075.78450 |
Ejemplares similares
-
Authors’ Reply
por: Tendas, Andrea, et al.
Publicado: (2011) -
Management of Peritoneal Dialysis within a Home Care Program for Hematological Malignancies: Concerns and Perspectives Illustrated by a Case Report
por: Vischini, Gisella, et al.
Publicado: (2011) -
Managing myelodysplastic syndromes in very old patients: a teaching case report
por: Niscola, Pasquale, et al.
Publicado: (2013) -
Long-term survival of a patient with bone marrow gelatinous degeneration of idiopathic origin
por: Niscola, Pasquale, et al.
Publicado: (2012) -
Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
por: Palombi, Massimiliano, et al.
Publicado: (2016)